NCT05597878 2026-03-06
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Wake Forest University Health Sciences
Phase 2/3 Suspended
Clinical Trials
41 trialsNCT07426055 2026-02-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT07426094 2026-02-23
PRO-BOOST-N
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT03258320 2026-01-12
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting
NCT03701581 2025-12-17
4-aminopyridine Treatment for Nerve Injury
University of Arizona
Phase 2/3 Recruiting
NCT03772834 2025-10-10
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
NCT07209878 2025-10-07
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
First Affiliated Hospital of Fujian Medical University
Phase 2/3 Recruiting
NCT05137561 2025-08-07
PROBIOP
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2/3 Completed
NCT03822845 2025-04-17
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT03525288 2025-03-13
PSMA-PETgRT
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2/3 Active not recruiting
NCT06601205 2024-09-19
2F
Ente Ospedaliero Ospedali Galliera
Phase 2/3 Completed
NCT03389451 2024-07-12
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT05627752 2024-02-28
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage
Zhongnan Hospital
Phase 2/3 Unknown
NCT06282588 2024-02-28
THUNDER
Cancer Research Antwerp
Phase 2/3 Recruiting
NCT03388346 2024-02-15
68Ga PSMA in Preprostatectomy Patients
University of Iowa
Phase 2/3 Completed
NCT04242017 2023-12-13
LOBSTER
Universitaire Ziekenhuizen KU Leuven
Phase 2/3 Recruiting
NCT03459820 2023-11-27
Prostate Cancer Patient Management With 18F-DCFPyL PET/CT
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2/3 Enrolling by invitation
NCT00584532 2023-11-24
GCP
University of California, Davis
Phase 2/3 Completed
NCT04654338 2023-06-27
EARTH
Sunnybrook Health Sciences Centre
Phase 2/3 Recruiting
NCT05841992 2023-05-03
Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
Peking Union Medical College Hospital
Phase 2/3 Unknown
NCT03103152 2023-03-29
PROVENT
Queen Mary University of London
Phase 2/3 Completed
NCT04627896 2023-02-02
Targeted Microwave Focal Therapy
A.O.U. Città della Salute e della Scienza
Phase 2/3 Completed
NCT03879122 2022-10-26
A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
Spanish Oncology Genito-Urinary Group
Phase 2/3 Unknown
NCT02673151 2022-01-13
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
Stanford University
Phase 2/3 Completed
NCT01902823 2019-12-13
Effect of Cancer Nurse Navigators on Patient Outcomes
University of Wisconsin, Madison
Phase 2/3 Terminated
NCT02759783 2019-08-21
CORE
Royal Marsden NHS Foundation Trust
Phase 2/3 Unknown
NCT01105338 2018-01-23
ProDiet
University of Bristol
Phase 2/3 Completed
NCT03344822 2017-11-17
TePSMAG-68
Central Hospital, Nancy, France
Phase 2/3 Unknown
NCT02016040 2017-04-19
Focal Therapy Using HIFU for Localised Prostate Cancer
Jewish General Hospital
Phase 2/3 Unknown
NCT02935972 2017-01-23
Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy
Assiut University
Phase 2/3 Completed
NCT02265159 2016-10-27
Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer
University of Zurich
Phase 2/3 Unknown
NCT00553878 2016-10-14
AVIAS
Canadian Urology Research Consortium
Phase 2/3 Completed
NCT00381836 2015-12-04
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer
University of Aarhus
Phase 2/3 Terminated
NCT01715064 2014-02-10
Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients
University of Guelph-Humber
Phase 2/3 Completed
NCT00922129 2014-01-14
Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer
St. Joseph's Healthcare Hamilton
Phase 2/3 Withdrawn
NCT01901042 2013-07-17
Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms
Federal University of Mato Grosso
Phase 2/3 Completed
NCT01825642 2013-04-05
Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer
University of Michigan
Phase 2/3 Completed
NCT01272648 2013-01-29
RePCa
Odense University Hospital
Phase 2/3 Completed
NCT00127387 2012-06-26
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
The University of Texas Health Science Center at San Antonio
Phase 2/3 Terminated
NCT00136487 2009-12-09
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
Dana-Farber Cancer Institute
Phase 2/3 Completed
NCT00421694 2007-10-08
Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide
University of L'Aquila
Phase 2/3 Completed